Research areas include: Liver protection Weight loss prevention Cellular recovery after toxic stress Reduction of chemotherapy-associated damage Further investigation is required to better understand these mechanisms
Supplementing with NAD may help support cognitive function, cellular energy production, and immune system function
In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Kim JW, Autry AE, Na ES, Adachi M, Bjrkholm C, Kavalali ET, et al